Developer docs
API playgroundTry for free, no card

Search company profiles

ScandiDos

Full company profile

uuid000l26m

Namestring
ScandiDos
Legal namestring
ScandiDos AB
Websiteurl
scandidos.com
Company typeenum
Public
Founded yearint
2006
Descriptiontext

ScandiDos AB (legal name ScandiDos AB, org number 556613-0927) is a Swedish medical technology company headquartered at Uppsala Science Park that develops, manufactures, and sells the Delta4 Family of quality assurance solutions for radiation therapy. Its core offering is the Delta4 Phantom+, a measurement phantom paired with proprietary calculation software that allows radiation oncologists and medical physicists to verify that complex radiotherapy treatments (including VMAT, RapidArc, IMRT, and Tomotherapy) are delivered as planned, with the upcoming Delta4 SRS Pro extending the same quality assurance concept into stereotactic radiosurgery.

The company operates a B2B enterprise field-sales model, selling primarily into hospitals and specialized radiotherapy clinics through wholly-owned subsidiaries in Sweden (HQ), the USA (Verona, WI), France (Paris), and China (Beijing), supplemented by a global distributor network. Revenue is generated through sale of proprietary hardware phantoms and associated QA software, with no public pricing disclosed but enterprise-style custom pricing typical of regulated medical devices; the company cites a deployed base of over 850 radiotherapy clinics across more than 55 countries as the primary scale indicator.

ScandiDos has been publicly listed on NASDAQ OMX First North (ticker SDOS) since April 11, 2014, and runs with 11-50 employees under an acting CEO, Anders Murman, who was appointed in May 2026 alongside CFO Henriette Münch (since December 2021) and VP Global Service and Product Management Mikael Palm (since 2012). The largest shareholder is Spore Invest AB, holding approximately 32.4% and associated with RTI Group, which subscribed 4.2 MSEK of the 4.3 MSEK committed to a 12.8 MSEK rights issue approved in June 2026 to fund the Delta4 SRS Pro launch.

Short descriptiontext

ScandiDos AB is a Swedish medical technology company that develops and sells the Delta4 Family of measurement phantoms and QA software, enabling radiotherapy clinics in over 55 countries to verify the accuracy of complex radiation therapy treatments including VMAT, RapidArc, IMRT, and Tomotherapy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersUppsala, Sweden
HQ citystring
Uppsala
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiation therapy QA, dosimetry verification systems, medical measurement phantoms, radiotherapy quality assurance, stereotactic radiosurgery QA
Industry2 codes
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAIAGAJ
Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine
NAICS code1 code
  • Irradiation Apparatus Manufacturing334517
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Radiation Therapy Quality Assurance
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device and Software Sales
TypeHardware Sales
Description

ScandiDos generates revenue through the sale of proprietary measurement phantoms (Delta4 Family hardware) and associated QA software solutions for radiotherapy clinics. The company operates in the medical technology sector targeting radiation therapy quality assurance, with revenue derived from both product sales and ongoing service/support.

scandidos.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Delta4 Family
Description

Comprehensive quality assurance solution for radiation therapy, including measurement phantoms and advanced software for QA and validation of dynamic and modulated treatments.

scandidos.com
Core offering1 text field

ScandiDos manufactures and sells the Delta4 Family of quality assurance products for radiation therapy, including proprietary measurement phantoms (Delta4 Phantom+) and QA/dosimetry verification software. These products are used by doctors and hospital physicists to verify that complex radiation cancer treatments, including VMAT, RapidArc, IMRT, and Tomotherapy, are delivered safely and correctly. The portfolio is established as the gold standard for radiation therapy QA since 2006.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over 850 clinics worldwide rely on Delta4 Family for radiation therapy QA
Product overview1 text field

ScandiDos offers the Delta4 Family of products, a comprehensive quality assurance solution for radiation therapy clinics. The portfolio centers on the Delta4 Phantom+ measurement system with its unique measurement technology and advanced calculation software, supplemented by the Delta4 SRS Pro for stereotactic radiosurgery QA. The Delta4 Family has been the gold standard for QA in advanced radiation therapy techniques including VMAT, RapidArc, IMRT, and Tomotherapy since 2006.

Product and service3 records
1Delta4 Family
CategoryRadiation Therapy Quality Assurance
Description

Comprehensive quality assurance solution for radiation therapy, established as the gold standard for QA in advanced radiation therapy techniques including VMAT, RapidArc, IMRT, and Tomotherapy. Deployed in over 850 radiotherapy clinics across more than 55 countries worldwide; for hospital physicists and radiation oncology teams that need to verify complex radiation treatments are delivered accurately and safely as planned.

2Delta4 Phantom+
CategoryRadiation Therapy Quality Assurance
Description

Measurement phantom with unique measurement technology and advanced calculation software that helps doctors and hospital physicists ensure that cancer radiation treatments are delivered correctly; deployed as the core physical measurement component of the Delta4 Family QA platform.

3Delta4 SRS Pro
CategoryRadiation Therapy Quality Assurance
Description

QA system designed for stereotactic radiosurgery (SRS), expanding the Delta4 Family to cover SRS treatment verification. Funded for launch and commercialization through ScandiDos's June 2026 rights issue; targets radiation oncology and SRS clinics requiring dedicated SRS quality assurance.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sun Nuclear is the closest direct competitor to ScandiDos, offering a broad portfolio of dosimetry phantoms, QA software and patient-specific QA solutions used by the same radiotherapy clinics ScandiDos serves with the Delta4 Family.

TypeDirect peer
Description

IBA Dosimetry provides detectors, phantoms and QA software for radiation therapy and is a direct competitor to ScandiDos in clinical dosimetry and patient QA workflows.

TypeDirect peer
Description

PTW is a long-established manufacturer of dosimetry detectors and QA equipment for radiation therapy, directly competing with ScandiDos in phantoms and measurement technology for radiotherapy clinics.

TypeDirect peer
Description

Standard Imaging designs and sells QA phantoms, detectors and software for radiation therapy, making it a direct competitor in the patient-specific and machine QA categories that ScandiDos addresses.

TypeDirect peer
Description

Modus Medical Devices (now part of Qaelum) provides phantoms and QA software for radiation therapy, competing with ScandiDos in routine and advanced radiotherapy QA.

6CIRS (Computerized Imaging Reference Systems)
TypeDirect peer
Description

CIRS manufactures tissue-equivalent and QA phantoms used in radiation therapy and diagnostic imaging, overlapping with ScandiDos's phantom-based QA offering for radiotherapy clinics.

TypeBroad incumbent
Description

Varian is a dominant radiotherapy equipment and treatment planning vendor whose ecosystem increasingly includes QA capabilities, posing an indirect but powerful competitive threat to a specialist QA vendor like ScandiDos.

TypeBroad incumbent
Description

Elekta is a major linac and radiosurgery vendor serving the same radiotherapy clinics as ScandiDos and is expanding its QA, planning and software portfolio, making it a broad incumbent peer.

TypeEmerging player
Description

RaySearch develops treatment planning and oncology informatics software used by radiotherapy clinics, making it an adjacent peer that intersects with ScandiDos's QA customers and even shares former employees with the company.

TypeEmerging player
Description

LAP provides laser-based patient positioning and QA systems for radiation therapy, making it an adjacent peer whose products are frequently purchased alongside ScandiDos phantoms at the same radiotherapy clinics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ScandiDos

Radiation Therapy Quality Assurancescandidos.com

ScandiDos AB is a Swedish medical technology company that develops and sells the Delta4 Family of measurement phantoms and QA software, enabling radiotherapy clinics in over 55 countries to verify the accuracy of complex radiation therapy treatments including VMAT, RapidArc, IMRT, and Tomotherapy.

What ScandiDos does

ScandiDos AB (legal name ScandiDos AB, org number 556613-0927) is a Swedish medical technology company headquartered at Uppsala Science Park that develops, manufactures, and sells the Delta4 Family of quality assurance solutions for radiation therapy. Its core offering is the Delta4 Phantom+, a measurement phantom paired with proprietary calculation software that allows radiation oncologists and medical physicists to verify that complex radiotherapy treatments (including VMAT, RapidArc, IMRT, and Tomotherapy) are delivered as planned, with the upcoming Delta4 SRS Pro extending the same quality assurance concept into stereotactic radiosurgery.

The company operates a B2B enterprise field-sales model, selling primarily into hospitals and specialized radiotherapy clinics through wholly-owned subsidiaries in Sweden (HQ), the USA (Verona, WI), France (Paris), and China (Beijing), supplemented by a global distributor network. Revenue is generated through sale of proprietary hardware phantoms and associated QA software, with no public pricing disclosed but enterprise-style custom pricing typical of regulated medical devices; the company cites a deployed base of over 850 radiotherapy clinics across more than 55 countries as the primary scale indicator.

ScandiDos has been publicly listed on NASDAQ OMX First North (ticker SDOS) since April 11, 2014, and runs with 11-50 employees under an acting CEO, Anders Murman, who was appointed in May 2026 alongside CFO Henriette Münch (since December 2021) and VP Global Service and Product Management Mikael Palm (since 2012). The largest shareholder is Spore Invest AB, holding approximately 32.4% and associated with RTI Group, which subscribed 4.2 MSEK of the 4.3 MSEK committed to a 12.8 MSEK rights issue approved in June 2026 to fund the Delta4 SRS Pro launch.

ScandiDos firmographics

Firmographics
Name
ScandiDos
Legal name
ScandiDos AB
Website
https://scandidos.com
Company type
Public
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
ScandiDos AB is a Swedish medical technology company that develops and sells the Delta4 Family of measurement phantoms and QA software, enabling radiotherapy clinics in over 55 countries to verify the accuracy of complex radiation therapy treatments including VMAT, RapidArc, IMRT, and Tomotherapy.
Ownership category
akta.pro rank

ScandiDos industry classification

Industry
Product category
Radiation Therapy Quality Assurance
NAICS
Irradiation Apparatus Manufacturing (334517)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAKAFAC
Radiation Oncology
SECONDARYHLAIAGAJ
Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

Keywords

  • Radiation therapy QA
  • Dosimetry verification systems
  • Medical measurement phantoms
  • Radiotherapy quality assurance
  • Stereotactic radiosurgery QA

Where ScandiDos is headquartered

Location

Headquarters

HQ city
Uppsala
HQ country
Sweden
HQ region
Europe

Offices4 records

Markets served

ScandiDos business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Device and Software Sales: ScandiDos generates revenue through the sale of proprietary measurement phantoms (Delta4 Family hardware) and associated QA software solutions for radiotherapy clinics. The company operates in the medical technology sector targeting radiation therapy quality assurance, with revenue derived from both product sales and ongoing service/support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

ScandiDos product offering

Product offering

Core offering

ScandiDos manufactures and sells the Delta4 Family of quality assurance products for radiation therapy, including proprietary measurement phantoms (Delta4 Phantom+) and QA/dosimetry verification software. These products are used by doctors and hospital physicists to verify that complex radiation cancer treatments, including VMAT, RapidArc, IMRT, and Tomotherapy, are delivered safely and correctly. The portfolio is established as the gold standard for radiation therapy QA since 2006.

Product overview

ScandiDos offers the Delta4 Family of products, a comprehensive quality assurance solution for radiation therapy clinics. The portfolio centers on the Delta4 Phantom+ measurement system with its unique measurement technology and advanced calculation software, supplemented by the Delta4 SRS Pro for stereotactic radiosurgery QA. The Delta4 Family has been the gold standard for QA in advanced radiation therapy techniques including VMAT, RapidArc, IMRT, and Tomotherapy since 2006.

Differentiator

Problem solved

Functional benefit

Brands

  • Delta4 Family: Comprehensive quality assurance solution for radiation therapy, including measurement phantoms and advanced software for QA and validation of dynamic and modulated treatments.

Products and services

  • Delta4 Family Comprehensive quality assurance solution for radiation therapy, established as the gold standard for QA in advanced radiation therapy techniques including VMAT, RapidArc, IMRT, and Tomotherapy. Deployed in over 850 radiotherapy clinics across more than 55 countries worldwide; for hospital physicists and radiation oncology teams that need to verify complex radiation treatments are delivered accurately and safely as planned.
  • Delta4 Phantom+ Measurement phantom with unique measurement technology and advanced calculation software that helps doctors and hospital physicists ensure that cancer radiation treatments are delivered correctly; deployed as the core physical measurement component of the Delta4 Family QA platform.
  • Delta4 SRS Pro QA system designed for stereotactic radiosurgery (SRS), expanding the Delta4 Family to cover SRS treatment verification. Funded for launch and commercialization through ScandiDos's June 2026 rights issue; targets radiation oncology and SRS clinics requiring dedicated SRS quality assurance.

Quantifiable outcome

  • Over 850 clinics worldwide rely on Delta4 Family for radiation therapy QA

Companies that use ScandiDos

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

ScandiDos technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

ScandiDos partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ScandiDos competitors and assessment

Company assessment

Direct peers

  • Sun Nuclear (Mirion Technologies): Sun Nuclear is the closest direct competitor to ScandiDos, offering a broad portfolio of dosimetry phantoms, QA software and patient-specific QA solutions used by the same radiotherapy clinics ScandiDos serves with the Delta4 Family.
  • IBA Dosimetry: IBA Dosimetry provides detectors, phantoms and QA software for radiation therapy and is a direct competitor to ScandiDos in clinical dosimetry and patient QA workflows.
  • PTW (Physikalisch-Technische Werkstätten): PTW is a long-established manufacturer of dosimetry detectors and QA equipment for radiation therapy, directly competing with ScandiDos in phantoms and measurement technology for radiotherapy clinics.
  • Standard Imaging: Standard Imaging designs and sells QA phantoms, detectors and software for radiation therapy, making it a direct competitor in the patient-specific and machine QA categories that ScandiDos addresses.
  • Modus Medical Devices: Modus Medical Devices (now part of Qaelum) provides phantoms and QA software for radiation therapy, competing with ScandiDos in routine and advanced radiotherapy QA.
  • CIRS (Computerized Imaging Reference Systems): CIRS manufactures tissue-equivalent and QA phantoms used in radiation therapy and diagnostic imaging, overlapping with ScandiDos's phantom-based QA offering for radiotherapy clinics.

Broad incumbents

  • Varian Medical Systems (Siemens Healthineers): Varian is a dominant radiotherapy equipment and treatment planning vendor whose ecosystem increasingly includes QA capabilities, posing an indirect but powerful competitive threat to a specialist QA vendor like ScandiDos.
  • Elekta: Elekta is a major linac and radiosurgery vendor serving the same radiotherapy clinics as ScandiDos and is expanding its QA, planning and software portfolio, making it a broad incumbent peer.

Emerging players

  • RaySearch Laboratories: RaySearch develops treatment planning and oncology informatics software used by radiotherapy clinics, making it an adjacent peer that intersects with ScandiDos's QA customers and even shares former employees with the company.
  • LAP (Laser Applications): LAP provides laser-based patient positioning and QA systems for radiation therapy, making it an adjacent peer whose products are frequently purchased alongside ScandiDos phantoms at the same radiotherapy clinics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

ScandiDos social profiles

Digital presence

ScandiDos financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ScandiDos leadership team

Management profile

Number of profiles

Profiles4 records

ScandiDos subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

ScandiDos funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ScandiDos M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ScandiDos

What does ScandiDos do?

ScandiDos manufactures and sells the Delta4 Family of quality assurance products for radiation therapy, including proprietary measurement phantoms (Delta4 Phantom+) and QA/dosimetry verification software. These products are used by doctors and hospital physicists to verify that complex radiation cancer treatments, including VMAT, RapidArc, IMRT, and Tomotherapy, are delivered safely and correctly. The portfolio is established as the gold standard for radiation therapy QA since 2006.

Is ScandiDos a public or private company?

ScandiDos is a public company. It is classified as public and is currently operating.

When was ScandiDos founded?

ScandiDos was founded in 2006. It employs 11 to 50 people.

Where is ScandiDos based?

ScandiDos is headquartered in Uppsala, Sweden, in the Europe region.

How does ScandiDos make money?

One revenue line is on record: medical Device and Software Sales.

Who are ScandiDos's main competitors?

Direct peers on record are Sun Nuclear (Mirion Technologies), IBA Dosimetry, PTW (Physikalisch-Technische Werkstätten), Standard Imaging, Modus Medical Devices and CIRS (Computerized Imaging Reference Systems). Broad incumbents are Varian Medical Systems (Siemens Healthineers) and Elekta. Emerging players are RaySearch Laboratories and LAP (Laser Applications).

Does ScandiDos have an API?

No public API is recorded for ScandiDos.

What industry is ScandiDos in?

ScandiDos's product category is Radiation Therapy Quality Assurance. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAIAGAJ, Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine). Its NAICS code is 334517 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dagens industriScandidos ska spara – skjuter upp lanseringScandidos is restructuring to cut costs and improve profitability at lower sales levels, and has delayed the Delta4 SRS Pro launch from late 2026 to the second half of 2027. The company aims to lower its cost base and improve solvency prospects.AInvestScandidos AB - share capital increases to SEK 3.56 mlnScandidos AB has increased its share capital to SEK 3.56 million, as reported in a news update dated July 28, 2026. The article provides no further details regarding the strategic implications or methods of this capital increase. This is a routine corporate administrative announcement.AffarsvarldenBevakning av Scandidos nyemission inledsMedical technology company Scandidos has decided on a rights issue that can bring in 12.8 Mkr before costs, with a subscription price of 0.90 kr per share representing a 10% discount to TERP. The funds will primarily be used for marketing and sales of the new Delta4 SRS Pro system (8 Mkr), regulatory approval costs (2.3 Mkr), and working capital (2 Mkr). The emission is secured to 33.1% through subscription commitments, with main shareholder RTI Group providing 4.2 Mkr of the 4.3 Mkr total committed.GlobeNewswireRadiology Oncology Systems, Inc. is the new distributor for ScandiDos products in the CaribbeanRadiology Oncology Systems, Inc. became the official distributor for ScandiDos products in the Caribbean. ScandiDos provides QA and dosimetry solutions for radiation therapy, with products used in over 600 clinics across 40 countries. The agreement was signed by ScandiDos's EVP and ROS's president.GlobeNewswireTrading in paid subscription shares (BTA) and subscription rights (TR) in ScandiDos AB (199/16)ScandiDos AB will trade its paid subscription shares (BTA) and subscription rights (TR) on First North starting September 30, 2016. BTA trading continues until further notice, while TR trading ends October 12, 2016. The information was distributed at the request of Certified Adviser Redeye AB.GlobeNewswireChange of Certified Adviser for ScandiDos AB (196/16)ScandiDos AB will change its certified adviser to Erik Penser Bank AB as of October 1, 2016. The change is distributed at the request of the current certified adviser, Redeye AB.PR NewswireScandiDos Unveils Delta4 Synthesis at ASTRO Annual Meeting in BostonSwedish medical device company ScandiDos unveiled its Delta4 Synthesis system, the world's first Non-Extrapolated Radiation Accuracy Measurement system, at the American Society for Radiation Oncology annual meeting in Boston on September 25-27, 2016. The system combines two FDA 510(k) cleared products—Delta4 Phantom+ and Delta4 Discover—into a comprehensive quality assurance solution for radiation therapy that provides exact independent measurements without mathematical extrapolation. ScandiDos CEO Görgen Nilsson stated the system addresses principal stakeholder needs by saving treatment set-up time for physicists while providing radiologists with assurance of delivered dose accuracy.GlobeNewswireC-RAD and ScandiDos have decided to end the cooperation on the North American marketC-RAD and ScandiDos ended their North American sales cooperation, citing overlapping product offerings. The companies will now market via their own organizations, with ongoing projects finalized by July. Both firms will focus on their respective products in the US market.GlobeNewswireScandiDos and C-RAD have decided to end the cooperation on the North American marketScandiDos and C-RAD ended their North American sales cooperation in May 2014, citing overlapping product offerings. The companies will now market their products independently, with ongoing sales projects finalized by July. Both firms will focus on their respective product portfolios in the US market.GlobeNewswireNASDAQ OMX WELCOMES SCANDIDOS TO FIRST NORTHScandiDos shares began trading on First North at NASDAQ OMX Stockholm on April 11, 2014. The Uppsala-based health care company provides QA and dosimetry for radiation therapy and is the eighth to list on First North in 2014. NASDAQ OMX noted continued interest from healthcare companies seeking public capital.